Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- Registration Number
- NCT00014300
- Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of glufosfamide in treating patients who have recurrent glioblastoma multiforme.
- Detailed Description
OBJECTIVES: I. Determine the activity of glufosfamide, in terms of objective response rate and/or progression-free survival at 6 months, in patients with recurrent glioblastoma multiforme. II. Determine the duration of objective response in patients treated with this regimen. III. Determine the toxic effects and pharmacokinetic profile of this regimen in these patients.
OUTLINE: This is a multicenter study. Patients receive glufosfamide IV over 60 minutes on day 1. Treatment repeats every 3 weeks in the absence of disease progression or unacceptable toxicity. Patients with stable disease receive treatment for a minimum of 6 months or until progression. Patients with an objective complete response receive a maximum of 2 additional courses of treatment after confirmation of response. Patients are followed every 6 weeks until progression.
PROJECTED ACCRUAL: A total of 28 patients will be accrued for this study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (18)
Centre Jean Perrin
🇫🇷Clermont-Ferrand, France
CRLCC Nantes - Atlantique
🇫🇷Nantes-Saint Herblain, France
Centre Antoine Lacassagne
🇫🇷Nice, France
Institut Gustave Roussy
🇫🇷Villejuif, France
CHU Pitie-Salpetriere
🇫🇷Paris, France
University of Ioannina
🇬🇷Ioannina, Greece
Schneider Children's Medical Center of Israel
🇮🇱Petah-Tikva, Israel
Azienda Ospedaliera di Padova
🇮🇹Padova (Padua), Italy
Istituti Fisioterapici Ospitalieri - Roma
🇮🇹Rome, Italy
Kantonsspital - St. Gallen
🇨ðŸ‡St. Gallen, Switzerland
Centre Leon Berard
🇫🇷Lyon, France
Kaiser Franz Josef Hospital
🇦🇹Vienna (Wien), Austria
Centre Eugene Marquis
🇫🇷Rennes, France
Instituto Portugues de Oncologia de Francisco Gentil
🇵🇹Lisbon, Portugal
Academisch Ziekenhuis Utrecht
🇳🇱Utrecht, Netherlands
Centre de Lute Contre le Cancer,Georges-Francois Leclerc
🇫🇷Dijon, France
Centre Hospitalier Universitaire Vaudois
🇨ðŸ‡Lausanne, Switzerland
Rotterdam Cancer Institute
🇳🇱Rotterdam, Netherlands